Since currently there is no clear understanding of the mechanism by which COX-2 facilitates the progression of cancer, our studies suggest a strategy for assessing the COX-2 pathway through elucidating possible downstream signaling mediators that have effects on the migration, invasion and expression of MMPs by highly invasive breast cancer cell lines. This evidence concerns the gene PTGS2 and breast carcinoma.